IONIS PHARMACEUTICALS INC Quarterly Interest Expense in USD from Q1 2010 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Ionis Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q2 2024.
Ionis Pharmaceuticals Inc Interest Expense for the quarter ending June 30, 2024 was $4.49M, a 96% increase year-over-year.
Ionis Pharmaceuticals Inc Interest Expense for the twelve months ending June 30, 2024 was $17.4M, a 124% increase year-over-year.
Ionis Pharmaceuticals Inc annual Interest Expense for 2023 was $12.7M, a 55.9% increase from 2022.
Ionis Pharmaceuticals Inc annual Interest Expense for 2022 was $8.12M, a 13.1% decline from 2021.
Ionis Pharmaceuticals Inc annual Interest Expense for 2021 was $9.35M, a 1.69% decline from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$17.4M	$4.49M	+$2.2M	+96%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-01
Q1 2024	$15.2M	$4.15M	+$2.54M	+158%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$12.7M	$4.56M	+$2.83M	+163%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-21
Q3 2023	$9.83M	$4.2M	+$2.06M	+96.5%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$7.77M	$2.29M	+$161K	+7.56%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-01
Q1 2023	$7.61M	$1.61M	-$514K	-24.2%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	$8.12M	$1.73M	-$507K	-22.7%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-21
Q3 2022	$8.63M	$2.14M	-$201K	-8.59%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	$8.83M	$2.13M	-$227K	-9.63%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	$9.06M	$2.12M	-$292K	-12.1%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-03
Q4 2021	$9.35M	$2.24M	-$196K	-8.05%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-21
Q3 2021	$9.55M	$2.34M	-$88K	-3.62%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021	$9.63M	$2.36M	-$84K	-3.44%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	$9.72M	$2.41M	+$207K	+9.38%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-04
Q4 2020	$9.51M	$2.43M	+$25.4M		Oct 1, 2020	Dec 31, 2020	10-K	2023-02-22
Q3 2020	-$15.9M	$2.43M	-$9.57M	-79.8%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-03
Q2 2020	-$6.31M	$2.44M	-$9.36M	-79.3%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	$3.05M	$2.21M	-$9.39M	-81%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	$12.4M	-$23M	-$34.4M	-300%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-25
Q3 2019	$46.9M	$12M	+$720K	+6.38%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-04
Q2 2019	$46.1M	$11.8M	+$689K	+6.2%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-05
Q1 2019	$45.5M	$11.6M	+$661K	+6.04%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-06
Q4 2018	$44.8M	$11.5M	+$670K	+6.21%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-24
Q3 2018	$44.1M	$11.3M	+$457K	+4.22%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-06
Q2 2018	$43.7M	$11.1M	-$665K	-5.65%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	$44.3M	$10.9M	-$425K	-3.74%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q4 2017	$44.8M	$10.8M	+$852K	+8.58%	Oct 1, 2017	Dec 31, 2017	10-K	2020-03-02
Q3 2017	$43.9M	$10.8M	+$1.08M	+11.1%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-06
Q2 2017	$42.8M	$11.8M	+$2.15M	+22.4%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-07
Q1 2017	$40.7M	$11.4M	+$1.87M	+19.7%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-07
Q4 2016	$38.8M	$9.93M	+$583K	+6.24%	Oct 1, 2016	Dec 31, 2016	10-K	2019-03-01
Q3 2016	$38.2M	$9.75M	+$513K	+5.56%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-07
Q2 2016	$37.7M	$9.63M	+$498K	+5.46%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-09
Q1 2016	$37.2M	$9.49M	+$469K	+5.2%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-09
Q4 2015	$36.7M	$9.35M	+$2.04M	+28%	Oct 1, 2015	Dec 31, 2015	10-K	2018-02-28
Q3 2015	$34.7M	$9.23M	+$4.24M	+84.7%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09
Q2 2015	$30.5M	$9.13M	+$4.17M	+84%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-09
Q1 2015	$26.3M	$9.02M	+$4.08M	+82.5%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-05
Q4 2014	$22.2M	$7.31M	+$2.42M	+49.6%	Oct 1, 2014	Dec 31, 2014	10-K	2017-03-01
Q3 2014	$19.8M	$5M	+$131K	+2.69%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-09
Q2 2014	$19.7M	$4.96M	+$153K	+3.18%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-05
Q1 2014	$19.5M	$4.94M	+$148K	+3.09%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-05
Q4 2013	$19.4M	$4.89M	+$68K	+1.41%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-26
Q3 2013	$19.3M	$4.87M	-$1.07M	-18%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-07
Q2 2013	$20.4M	$4.81M	-$411K	-7.88%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-04
Q1 2013	$20.8M	$4.8M	-$384K	-7.42%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-06
Q4 2012	$21.2M	$4.82M	-$290K	-5.68%	Oct 1, 2012	Dec 31, 2012	10-K	2015-03-02
Q3 2012	$21.4M	$5.94M	+$1.16M	+24.4%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-05
Q2 2012	$20.3M	$5.22M	+$1.78M	+51.8%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-06
Q1 2012	$18.5M	$5.18M	+$1.76M	+51.7%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-07
Q4 2011	$16.7M	$5.11M	+$1.71M	+50.4%	Oct 1, 2011	Dec 31, 2011	10-K	2014-03-03
Q3 2011	$15M	$4.77M	+$1.44M	+43%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-06
Q2 2011	$13.6M	$3.44M	+$176K	+5.4%	Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-06
Q1 2011	$13.4M	$3.42M	+$178K	+5.5%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-09
Q4 2010	$13.2M	$3.4M			Oct 1, 2010	Dec 31, 2010	10-K	2013-02-28
Q3 2010		$3.34M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-08
Q2 2010		$3.26M			Apr 1, 2010	Jun 30, 2010	10-Q	2011-08-08
Q1 2010		$3.24M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-05-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.